Abstract
Neuropathic pain is a frequent condition caused by a lesion or disease of the central or peripheral somatosensory nervous system. A frequent cause of peripheral neuropathic pain is diabetic neuropathy. Its complex pathophysiology is not yet fully elucidated, which contributes to underassessment and undertreatment. A mechanism-based treatment of painful diabetic neuropathy is challenging but phenotype-based stratification might be a way to develop individualized therapeutic concepts. Our goal is to review current knowledge of the pathophysiology of peripheral neuropathic pain, particularly painful diabetic neuropathy. We discuss state-of-the-art clinical assessment, validity of diagnostic and screening tools, and recommendations for the management of diabetic neuropathic pain including approaches towards personalized pain management. We also propose a research agenda for translational research including patient stratification for clinical trials and improved preclinical models in relation to current knowledge of underlying mechanisms.
Original language | English |
---|---|
Pages (from-to) | 589-624 |
Number of pages | 36 |
Journal | Journal of Neural Transmission |
Volume | 127 |
Issue number | 4 |
Early online date | 8-Feb-2020 |
DOIs | |
Publication status | Published - Apr-2020 |
Keywords
- Painful diabetic neuropathy
- Spinal sensitization
- Neuroinflammation
- Quantitative sensory testing
- Stratification in clinical trials
- Personalized pain management
- PERIPHERAL-NERVE INJURY
- GATED SODIUM-CHANNELS
- ALPHA-LIPOIC ACID
- DIAGNOSE DISTAL POLYNEUROPATHY
- CONTROLLED-RELEASE OXYCODONE
- RANDOMIZED CONTROLLED-TRIAL
- GERMAN RESEARCH NETWORK
- HUMAN SURROGATE MODELS
- PROTEIN-KINASE-C
- DOUBLE-BLIND